Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease
1998

Hepatitis B Virus Exposure and Liver Cancer Risk

Sample size: 292 publication Evidence: moderate

Author Information

Author(s): S Okada, T Sato, T Okusaka, H Ishii, M Ikeda, H Nakasuka, H Kosakamoto, M Yoshimori, K Wakabayashi

Primary Institution: National Cancer Center Hospital

Hypothesis

Does past exposure to hepatitis B virus influence the risk of developing hepatocellular carcinoma in patients with chronic liver disease?

Conclusion

Past exposure to hepatitis B virus is a significant risk factor for hepatocellular carcinoma in Japanese patients with chronic liver disease.

Supporting Evidence

  • 65% of HCC patients were anti-HBc positive compared to 43% of CLD controls.
  • Anti-HBc positivity significantly increased the risk of developing HCC.
  • Patients positive for anti-HBc alone had a higher risk of HCC compared to those with transient HBV infection.

Takeaway

If someone has had hepatitis B in the past, they might be more likely to get liver cancer, especially if they don't have signs of being immune to it.

Methodology

A hospital-based case-control study comparing 141 HCC patients with chronic liver disease to 151 controls with chronic liver disease but without HCC.

Potential Biases

Potential biases may arise from the case-control design and selection of participants.

Limitations

The study is limited to Japanese patients, and findings may not be generalizable to other populations.

Participant Demographics

141 HCC patients (110 men, 31 women) with a mean age of 61.4 years; 151 CLD controls (96 men, 55 women) with a mean age of 55.9 years.

Statistical Information

P-Value

0.01

Confidence Interval

95% CI

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication